A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. (2014)
Attributed to:
Exploitation of mouse models to validate protein kinases as drug targets
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/nm.3646
PubMed Identifier: 25326799
Publication URI: http://europepmc.org/abstract/MED/25326799
Type: Journal Article/Review
Volume: 20
Parent Publication: Nature medicine
Issue: 11
ISSN: 1078-8956